Ovarian PRP for Diminished Ovarian Reserve
ConditionDiminished Ovarian Reserve
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age35-42
SponsorGeneration Next Fertility
About this trial
This prospective double-blinded randomized placebo control study aims to determine if In Vitro Fertilization (IVF) outcomes are improved by ovarian platelet-rich plasma injections (oPRP) for women diagnosed with diminished ovarian reserve (DOR). Women with DOR notoriously have the lowest chance of pregnancy and live birth compared to age-matched peers with a normal or robust ovarian reserve.
Eligibility criteria
Qualifiers
Clinical diagnosis of diminished ovarian reserve
Clinical diagnosis of poor ovarian response
Women age 35-42
Disqualifiers
Clinical diagnosis of premature ovarian failure
Clinical diagnosis of menopause.
Under 35 years of age
Over 42 years of age
Trial design
Treatments tested in this trial
- oPRP
- Placebo- Serum
Treatment groups
230 Participants
are divided into 2 treatment groupsSponsors and collaborators
Generation Next Fertility
Lead sponsor
Igenomix
Collaborator
Source ClinicalTrials.gov